Last week Brisbane medtech company Vaxxas, which is trying to reinvent the needle, announced plans to move to industrial-scale production. Brent Balinski spoke to the company’s Dr Angus Forster about getting from invention to impact.
Listed food manufacturer Longtable, which makes the Maggie Beer range of luxury products, has stepped up its online business as Covid-19 lockdowns and restaurant closures affected sales growth, with the downturn especially apparent in April. The Barossa Valley company told investors that its St David Dairy and Paris Creek dairy businesses had been hit by…
The Australian Made Campaign Ltd (AMCL), the organisation responsible for the famous Australian Made log, has urged all Australians to buy Australian made goods and Australian grown foods. Australian Made Chief Executive, Ben Lazzaro made the call when announcing a new buy local campaign tag lined ‘It’s never been more important to buy Australian than…
Although there are some jobs machines just can’t do, COVID-19 has left us wondering about the future of work and with this, the capacity of automation to step in where humans must step back.
Pharmaceutical giant MSD will use Vaxxas’s syringe-free vaccination platform on an unnamed “vaccine candidate.”
RUAG Australia has been awarded a Defence grant to grow its capacity and supply chain resilience to support Defence and sustainment of aircraft. The Sovereign Industrial Capability Priority (SICP) grant will enhance efficiency and competitiveness of the company through modernising and automating capital equipment. It will also go towards aid capabilities in the manufacturing and…
Work on the long-awaited 280-megawatt Cultana Solar Farm in South Australia could begin as early as July. The project on a 1100ha site north of Whyalla on Eyre Peninsula is the first large scale project in billionaire industrialist Sanjeev Gupta’s plan to generate one gigawatt of dispatchable renewable energy in South Australia.
A roundtable chaired by the federal industry minister on Wednesday will hear from fashion industry leaders, following an “unprecedented” drop in sales through the Covid-19 pandemic.
Vitamin manufacturer Blackmores has announced a fully underwritten $92 million placement to institutional investors and a share purchase plan for existing shareholders to raise a further $25 million. The $117 million raising will be used to accelerate growth in Asia, invest in an efficiency programme and strengthen the Sydney company’s balance sheet. The company told…
A manufacturer in South Australia is thinking on its feet as it identifies gaps in the market during COVID-19 shut downs.
